Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice
暂无分享,去创建一个
S. Ochenduszko | E. Muñoz-Couselo | G. Crespo | J. Oramas | A. Rodríguez Garzotto | B. Campos Balea | M. Corral | P. Sancho | J. Medina | F. Garicano | M. Álamo | Pedro López